Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities

Autor:	Liberti, Lawrence, Breckenridge, Alasdair, Hoekman, Jarno, Leufkens, Hubert, Lumpkin, Murray, McAuslane, Neil, Stolk, Pieter, Zhi, Kaining, Rägo, Lembit
Zdroj:	Journal of Public Health Policy, 2016 Aug 01. 37(3), 315-333.
Databáze:	JSTOR Journals
Externí odkaz:	http://www.jstor.org/stable/43948863 Zobrazit plný text záznamu Full text from SpringerLink